You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -2,325.4% | -707.0% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -2.1 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 46.3 | 13.3 |
Price / Book value | 1.2 |
Latest | Forecast | |
---|---|---|
Revenue | 2.8% | -37.9% |
PBT | 0.0% | n/a |
EPS | 0.0% | -8.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-04-30 | 0.68 | -10.87 | -6.56p | -11.6 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | 0.58 | -9.04 | -6.88p | -9.1 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | 0.76 | -13.74 | -6.52p | -7.3 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 1.01 | -17.36 | -6.67p | -17.8 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | 1.04 | -24.44 | -8.97p | -5.6 | 0.0 | n/a | n/a | 0.0% |
Angle losses widen in 'breakthrough year' Sharecast News | 21 Apr |
---|---|
Tougher market conditions impacting Angle clients Sharecast News | 05 Jan |
Director dealings: Angle CEO, finance chief join capital raise Sharecast News | 19 Jul |
Pharma services contract with Artios Pharma | 25-May-23 14:43 |
---|---|
Board change - appointment of new Chairman | 22-May-23 14:34 |
Results for the year ended 31 December 2022 | 21-Apr-23 14:35 |
ANGLE announces partnership with BioView | 19-Apr-23 14:43 |
Pharma Services Contract with Crescendo Biologics | 13-Apr-23 14:51 |